Bank of America
NUVB icon

Bank of America’s Nuvation Bio NUVB Stock Holding History

Bank of America’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.8M Sell
3,219,826
-589,599
-15% -$3.28M ﹤0.01% 2706
2025
Q4 		$34.1M Buy
3,809,425
+3,180,263
+505% +$19.7M ﹤0.01% 1843
2025
Q3 		$2.33M Buy
629,162
+419,521
+200% +$1.14M ﹤0.01% 4697
2025
Q2 		$409K Buy
209,641
+106,278
+103% +$221K ﹤0.01% 5826
2025
Q1 		$182K Sell
103,363
-73,870
-42% -$168K ﹤0.01% 6228
2024
Q4 		$471K Sell
177,233
-91,737
-34% -$236K ﹤0.01% 5582
2024
Q3 		$616K Sell
268,970
-54,691
-17% -$167K ﹤0.01% 5358
2024
Q2 		$945K Sell
323,661
-41,665
-11% -$127K ﹤0.01% 4936
2024
Q1 		$1.33M Sell
365,326
-117,644
-24% -$226K ﹤0.01% 4745
2023
Q4 		$729K Buy
482,970
+244,891
+103% +$315K ﹤0.01% 5231
2023
Q3 		$319K Sell
238,079
-30,215
-11% -$50.3K ﹤0.01% 5627
2023
Q2 		$483K Sell
268,294
-239,158
-47% -$407K ﹤0.01% 5305
2023
Q1 		$842K Buy
507,452
+202,266
+66% +$410K ﹤0.01% 5017
2022
Q4 		$586K Buy
305,186
+100,738
+49% +$204K ﹤0.01% 5260
2022
Q3 		$457K Buy
204,448
+70,689
+53% +$202K ﹤0.01% 5476
2022
Q2 		$433K Buy
133,759
+83,353
+165% +$364K ﹤0.01% 5537
2022
Q1 		$265K Sell
50,406
-1,055
-2% -$5.93K ﹤0.01% 6289
2021
Q4 		$437K Buy
51,461
+35,363
+220% +$325K ﹤0.01% 5995
2021
Q3 		$160K Sell
16,098
-21,304
-57% -$193K ﹤0.01% 6444
2021
Q2 		$348K Buy
37,402
+37,359
+86,881% +$426K ﹤0.01% 5695
2021
Q1 		$0 Buy
+43
New +$481 ﹤0.01% 7663

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Bank of America's NUVB Position: Q1 2026 in Review

Bank of America reduced its Nuvation Bio (NUVB) stake by 15% in Q1 2026, selling an estimated $3.28M and leaving 3,219,826 shares worth $13.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2706.

Bank of America first reported a position in NUVB in Q1 2021 and has held it in 21 quarters since. The position peaked at $34.1M in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Bank of America held 3,219,826 shares of Nuvation Bio worth $13.8M as of Q1 2026.
  • Bank of America sold 589,599 Nuvation Bio shares in Q1 2026, an estimated $3.28M.
  • Nuvation Bio made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2706 holding.
  • Bank of America first reported a position in Nuvation Bio in Q1 2021 and has held it in 21 quarters since.
  • Bank of America's Nuvation Bio position peaked at $34.1M in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.